On the way to cure epilepsy

Expert Review of Neurotherapeutics

Volumn 4, Issue 6, 2004, Pages 917-920

  Pitkänen, Asla ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ATIPAMEZOLE; ION CHANNEL; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; BRAIN INJURY; CELL TRANSPLANTATION; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENOTYPE; GLIOSIS; IDIOPATHIC DISEASE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPHARMACOLOGY; NONHUMAN; PREVALENCE; SEIZURE;

ANIMALS; ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 8344290372     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.6.917     Document Type: Editorial

References (19)

1. Avanzini G, Franceschetti S. Cellular biology of epileptogenesis. Lancet Neurol. 2(1), 33-42 (2003).
2. Pitkänen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1(3), 173-181 (2002).
3. Stables JP, Bertram EH, White HS et al. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, MD, USA. Epilepsia 43(11), 1410-1420 (2002).
4. Stables JP, Bertram E, Dudek FE et al. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 44(12), 1472-1478 (2003).
5. Pitkänen A. New pharmacotherapy for epilepsy. Drugs 7(5), 471-477 (2004).
6. Pitkänen A, Kubova H. Antiepileptic drugs in neuroprotection. Expert Opin. Pharmacother. 5(4), 777-798 (2004).
7. Beghi E, Beghi M, Cornaggia C. Primary prevention of epilepsy in patients with different epileptogenic conditions. Expert Rev. Neurotherapeutics 4(6), 945-952 (2004).
8. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42(4), 515-524 (2001).
9. Noebels JL. The biology of epilepsy genes. Ann. Rev. Neurosci. 26, 599-625 (2003).
10. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann. Neurol. 44(6), 908-912 (1998).
11. Kelly KM, Kharlamov A, Hentosz TM et al. Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats. Epilepsy Res. 47(3), 189-203 (2001).
12. Kharatishvili I, Nissinen J, Mcintosh TK, Pitkänen A. A rat model for head trauma induced epileptogenesis in humans. Epilepsia 44(Suppl. 8), 36 (2003).
13. Bezvenyuk Z, Nissinen J, Pitkänen A. Photothrombotic brain infarction induced epileptogenesis in rats. Soc. Neurosci. Abst. 533, 15 (2003).
14. D'Ambrosio R, Fairbanks JP, Fender JS, Born DE, Doyle DL, Miller JW. Posttraumatic epilepsy following fluid percussion injury in the rat. Brain 127(Pt 2), 304-314 (2004).
15. Pitkänen A, Narkilahti S, Bezvenyuk Z, Haapalinna A, Nissinen J. Atipamezole, an a(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res. 61(1-3), 119-140 (2004).
16. Brandt C, Potschka H, Loscher W, Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118(3), 727-740 (2003).
17. Lukasiuk K, Pitkänen A. Large-scale analysis of gene expression in epilepsy research: is synthesis already possible? Neurochem. Res. 29(6), 1169-1178 (2004).
18. Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. Curr. Opin. Pharmacol. 3(1), 27-32 (2003).
19. Royo NC, Schouten JW, Fulp CT et al. From cell death to neuronal regeneration: building a new brain after traumatic brain injury. J. Neuropathol. Exp. Neurol. 62(8), 801-811 (2003).